Skip to content
PubMed This is a summary of 43 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 43 referenced papers

Top Authors

Amitabha Chattopadhyay
Centre for Cellular and Molecular Biology
Ned A. Porter
Vanderbilt University
Željka Korade
Nebraska Medical Center
Forbes D. Porter
National Institutes of Health
Libin Xu
University of Washington
Károly Mirnics
Nebraska Medical Center
Audrey Thurm
National Institute of Mental Health
Thiago C. Genaro‐Mattos
University of Nebraska Medical Center
Steven J. Fliesler
Anheuser-Busch InBev (Belgium)
Yuqin Wang
Swansea University

Top Institutions

Ranked by publications Top 10 institutions
07

National Institute of Mental Health

Bethesda, United States

11 papers

References

References (43)
  1. 1

    Reduced cholesterol levels impair Smoothened activation in Smith-Lemli-Opitz syndrome.

    Blassberg R, Macrae JI, Briscoe J, Jacob J

    Human molecular genetics 2016; (25(4)):693-705 doi:10.1093/hmg/ddv507.

    PMID: 26685159
  2. 2

    The p.Phe174Ser mutation is associated with mild forms of Smith Lemli Opitz Syndrome.

    Tucci A, Ronzoni L, Arduino C, et al.

    BMC medical genetics 2016; (17()):22 doi:10.1186/s12881-016-0287-1.

    PMID: 26969503
  3. 3

    Development, behavior, and biomarker characterization of Smith-Lemli-Opitz syndrome: an update.

    Thurm A, Tierney E, Farmer C, et al.

    Journal of neurodevelopmental disorders 2016; (8()):12 doi:10.1186/s11689-016-9145-x.

    PMID: 27053961
  4. 4

    Inhibitors of 7-Dehydrocholesterol Reductase: Screening of a Collection of Pharmacologically Active Compounds in Neuro2a Cells.

    Kim HY, Korade Z, Tallman KA, et al.

    Chemical research in toxicology 2016; (29(5)):892-900 doi:10.1021/acs.chemrestox.6b00054.

    PMID: 27097157
  5. 5

    Endogenous B-ring oxysterols inhibit the Hedgehog component Smoothened in a manner distinct from cyclopamine or side-chain oxysterols.

    Sever N, Mann RK, Xu L, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2016; (113(21)) doi:10.1073/pnas.1604984113.

    PMID: 27162362
  6. 6

    A Pilot Study of the Association of Markers of Cholesterol Synthesis with Disturbed Sleep in Smith-Lemli-Opitz Syndrome.

    Freeman KA, Olufs E, Tudor M, et al.

    Journal of developmental and behavioral pediatrics : JDBP 2016; (37(5)):424-30 doi:10.1097/DBP.0000000000000317.

    PMID: 27244299
  7. 7

    A placebo-controlled trial of simvastatin therapy in Smith-Lemli-Opitz syndrome.

    Wassif CA, Kratz L, Sparks SE, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(3)):297-305 doi:10.1038/gim.2016.102.

    PMID: 27513191
  8. 8

    Smith-Lemli-Opitz syndrome carrier frequency and estimates of in utero mortality rates.

    Lazarin GA, Haque IS, Evans EA, Goldberg JD

    Prenatal diagnosis 2017; (37(4)):350-355 doi:10.1002/pd.5018.

    PMID: 28166604
  9. 9

    Normal IQ is possible in Smith-Lemli-Opitz syndrome.

    Eroglu Y, Nguyen-Driver M, Steiner RD, et al.

    American journal of medical genetics. Part A 2017; (173(8)):2097-2100 doi:10.1002/ajmg.a.38125.

    PMID: 28349652
  10. 10

    Prenatal diagnosis of holoprosencephaly associated with Smith-Lemli-Opitz syndrome (SLOS) in a 46,XX fetus.

    Travessa A, Dias P, Rocha P, Sousa AB

    Taiwanese journal of obstetrics & gynecology 2017; (56(4)):541-544 doi:10.1016/j.tjog.2017.01.012.

    PMID: 28805615
  11. 11

    Smith-Lemli-Opitz syndrome: clinical and biochemical correlates.

    Donoghue SE, Pitt JJ, Boneh A, White SM

    Journal of pediatric endocrinology & metabolism : JPEM 2018; (31(4)):451-459 doi:10.1515/jpem-2017-0501.

    PMID: 29455191
  12. 12

    Smith-Lemli-Opitz syndrome presenting as acute adrenal crisis in a child: a case report.

    Jayamanne C, Sandamal S, Jayasundara K, et al.

    Journal of medical case reports 2018; (12(1)):217 doi:10.1186/s13256-018-1738-4.

    PMID: 30092813
  13. 13

    Lipid-derived and other oxidative modifications of retinal proteins in a rat model of Smith-Lemli-Opitz syndrome.

    Kapphahn RJ, Richards MJ, Ferrington DA, Fliesler SJ

    Experimental eye research 2019; (178()):247-254 doi:10.1016/j.exer.2018.08.006.

    PMID: 30114413
  14. 14

    Long-Term Cholic Acid Treatment in a Patient with Zellweger Spectrum Disorder.

    Heubi JE, Bishop WP

    Case reports in gastroenterology 2018; (12(3)):661-670 doi:10.1159/000494555.

    PMID: 30519152
  15. 15

    The Smith-Lemli-Opitz syndrome and dentofacial anomalies diagnostic: Case reports and literature review.

    Rojare C, Opdenakker Y, Laborde A, et al.

    International orthodontics 2019; (17(2)):375-383 doi:10.1016/j.ortho.2019.03.020.

    PMID: 31005410
  16. 16

    Smith-Lemli-Opitz syndrome - Fetal phenotypes with special reference to the syndrome-specific internal malformation pattern.

    Schoner K, Witsch-Baumgartner M, Behunova J, et al.

    Birth defects research 2020; (112(2)):175-185 doi:10.1002/bdr2.1620.

    PMID: 31840946
  17. 17

    Alazami syndrome: Phenotypic expansion and clinical resemblance to Smith-Lemli-Opitz syndrome.

    Gana S, Plumari M, Rossi E, et al.

    American journal of medical genetics. Part A 2020; (182(11)):2722-2726 doi:10.1002/ajmg.a.61832.

    PMID: 32888391
  18. 18

    [Clinical and genetic analysis of a Chinese pedigree affected with Smith-Lemli-Opitz syndrome].

    Gao C, Duan J, Zhang P, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020; (37(11)):1272-1275 doi:10.3760/cma.j.cn511374-20190929-00502.

    PMID: 33179238
  19. 19

    Familial DHCR7 genotype presenting as a very mild form of Smith-Lemli-Opitz syndrome and lethal holoprosencephaly.

    Temple SEL, Sachdev R, Ellaway C

    JIMD reports 2020; (56(1)):3-8 doi:10.1002/jmd2.12155.

    PMID: 33204589
  20. 20

    Prescription Medications Alter Neuronal and Glial Cholesterol Synthesis.

    Tallman KA, Allen LB, Klingelsmith KB, et al.

    ACS chemical neuroscience 2021; (12(4)):735-745 doi:10.1021/acschemneuro.0c00765.

    PMID: 33528983
  21. 21

    Auditory phenotype of Smith-Lemli-Opitz syndrome.

    Zalewski CK, Sydlowski SA, King KA, et al.

    American journal of medical genetics. Part A 2021; (185(4)):1131-1141 doi:10.1002/ajmg.a.62087.

    PMID: 33529473
  22. 22

    Sterol Biosynthesis Inhibition in Pregnant Women Taking Prescription Medications.

    Genaro-Mattos TC, Klingelsmith KB, Allen LB, et al.

    ACS pharmacology & translational science 2021; (4(2)):848-857 doi:10.1021/acsptsci.1c00012.

    PMID: 33860207
  23. 23

    A Case of Smith-Lemli-Opitz Syndrome Diagnosed with Hypertrophic Pyloric Stenosis.

    Eren EE, Bilgin N, Urganci N, Kose G

    Sisli Etfal Hastanesi tip bulteni 2021; (55(2)):268-271 doi:10.14744/SEMB.2020.34651.

    PMID: 34349606
  24. 24

    Biochemical and Clinical Effects of Vitamin E Supplementation in Hungarian Smith-Lemli-Opitz Syndrome Patients.

    Koczok K, Horváth L, Korade Z, et al.

    Biomolecules 2021; (11(8)) doi:10.3390/biom11081228.

    PMID: 34439893
  25. 25

    Smith-Lemli-Opitz Syndrome: Bosnian and Herzegovinian Experience.

    Begic N, Begic Z, Begic E

    Balkan journal of medical genetics : BJMG 2021; (24(1)):99-102 doi:10.2478/bjmg-2021-0002.

    PMID: 34447666
  26. 26

    A reliable tool for detecting 7-dehydrocholesterol and cholesterol in human plasma and its use in diagnosis of Smith-Lemli-Opitz syndrome.

    Luo Y, Liu Z, Zeng Y, et al.

    Journal of separation science 2022; (45(5)):1080-1093 doi:10.1002/jssc.202100594.

    PMID: 34962712
  27. 27

    Temporal changes in the brain lipidome during neurodevelopment of Smith-Lemli-Opitz syndrome mice.

    Li A, Hines KM, Ross DH, et al.

    The Analyst 2022; (147(8)):1611-1621 doi:10.1039/d2an00137c.

    PMID: 35293916
  28. 28

    Smith-Lemli-Optiz syndrome: importance of ophthalmology referral and follow-up.

    López-Cañizares A, Al-Khersan H, Fernandez MP, et al.

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2023; (27(2)):100-102 doi:10.1016/j.jaapos.2022.11.007.

    PMID: 36563894
  29. 29

    Smith-Lemli-Opitz syndrome: A pathophysiological manifestation of the Bloch hypothesis.

    Chattopadhyay A, Sharma A

    Frontiers in molecular biosciences 2023; (10()):1120373 doi:10.3389/fmolb.2023.1120373.

    PMID: 36714259
  30. 30

    Keeping you on your toes: Smith-Lemli-Opitz Syndrome is an easily missed cause of developmental delays.

    Coupe S, Hertzog A, Foran C, et al.

    Clinical case reports 2023; (11(2)):e6920 doi:10.1002/ccr3.6920.

    PMID: 36814711
  31. 31

    Cholic acid increases plasma cholesterol in Smith-Lemli-Opitz syndrome: A pilot study.

    Elias ER, Orth LE, Li A, et al.

    Molecular genetics and metabolism reports 2024; (38()):101030 doi:10.1016/j.ymgmr.2023.101030.

    PMID: 38077958
  32. 32

    Traumatic Self-Inflicted Ventricular Laceration: A Case of Smith-Lemli-Opitz Syndrome in an Adult.

    Beuschel JJ, Ng GI, Abaraoha JC, Fortuna RJ

    Cureus 2024; (16(2)):e53613 doi:10.7759/cureus.53613.

    PMID: 38449995
  33. 33

    DHCR7 links cholesterol synthesis with neuronal development and axonal integrity.

    Miyazaki S, Shimizu N, Miyahara H, et al.

    Biochemical and biophysical research communications 2024; (712-713()):149932 doi:10.1016/j.bbrc.2024.149932.

    PMID: 38626530
  34. 34

    Smith-Lemli-Opitz Syndrome with Biallelic c.1295A>G (p.Tyr432Cys) Variant in the DHCR7 Gene in a 73-Year-Old Woman: Report of the Oldest Patient.

    Yılmaz M, Bebek O, Turkyilmaz A

    Molecular syndromology 2024; (15(4)):317-323 doi:10.1159/000536343.

    PMID: 39119449
  35. 35

    Assessing Postnatal Mortality in Smith-Lemli-Opitz Syndrome.

    Selvaraman A, Rahhal S, Bianconi S, et al.

    American journal of medical genetics. Part A 2025; (197(2)):e63875 doi:10.1002/ajmg.a.63875.

    PMID: 39271956
  36. 36

    First documented case of Smith-Lemli-Opitz syndrome in Syria: clinical presentation, diagnosis, and experimental management with simvastatin.

    Aladia AH, Hamdan S, Alkheder A

    Oxford medical case reports 2024; (2024(11)):omae129 doi:10.1093/omcr/omae129.

    PMID: 39575090
  37. 37

    Smith-Lemli-Opitz Syndrome: Oral Characteristics and Risk Factors for Caries Development.

    Olczak-Kowalczyk D, Witt-Porczyk A, Piekoszewska-Ziętek P, Krajewska-Walasek M

    Biomedicines 2025; (13(3)) doi:10.3390/biomedicines13030574.

    PMID: 40149551
  38. 38

    Smith-Lemli-Opitz syndrome: Clinical, biochemical, and genetic insights with emerging treatment opportunities.

    Kritzer A, Dutta R, Pramparo T, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2025; (27(7)):101450 doi:10.1016/j.gim.2025.101450.

    PMID: 40314187
  39. 39

    The role of cholesterol biosynthesis and metabolism causing medical complexity in patients with Smith-Lemli-Opitz Syndrome (SLOS).

    Elias ER

    The Journal of steroid biochemistry and molecular biology 2025; (254()):106822 doi:10.1016/j.jsbmb.2025.106822.

    PMID: 40609800
  40. 40

    Use of cholic acid in Smith-Lemli-Opitz syndrome (SLOS): real-world patient outcomes.

    Ferren E, Hillman PR, Kritzer A, et al.

    Orphanet journal of rare diseases 2025; (20(1)):381 doi:10.1186/s13023-025-03914-x.

    PMID: 40722188
  41. 41

    Exploring Recent Developments in the Manifestation, Diagnosis, and Treatment of Patients with Smith-Lemli-Opitz Syndrome: From Molecular Pathways to Clinical Innovations.

    Żukowska A, Król M, Kupnicka P, et al.

    International journal of molecular sciences 2025; (26(14)) doi:10.3390/ijms26146672.

    PMID: 40724921
  42. 42

    Cross-sectional analysis of expressive and receptive language skills in Smith-Lemli-Opitz syndrome (SLOS).

    Morris SM, Tierney E

    Journal of rare diseases (Berlin, Germany) 2025; (4(1)):56 doi:10.1007/s44162-025-00119-5.

    PMID: 40979443
  43. 43

    Smith-Lemli-Opitz Syndrome (SLOS)-Case Description and the Impact of Therapeutic Interventions on Psychomotor Development.

    Kozera N, Śmigiel R, Rozensztrauch A

    Journal of clinical medicine 2025; (14(23)) doi:10.3390/jcm14238569.

    PMID: 41375871